182 related articles for article (PubMed ID: 1687773)
1. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
Koike K; Takayanagi I; Hirakura Y; Matsueda R
Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773
[TBL] [Abstract][Full Text] [Related]
2. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
Cox BM; Chavkin C
Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
[No Abstract] [Full Text] [Related]
4. The choice of opioid receptor subtype in isolated preparations by dynorphins.
Oka T; Aoki K; Kajiwara M
Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492
[TBL] [Abstract][Full Text] [Related]
5. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
Bell KM; Traynor JR
Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
[TBL] [Abstract][Full Text] [Related]
6. Opioid profiles of Cys2-containing enkephalin analogues.
Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
[TBL] [Abstract][Full Text] [Related]
7. PD117302: a selective agonist for the kappa-opioid receptor.
Clark CR; Birchmore B; Sharif NA; Hunter JC; Hill RG; Hughes J
Br J Pharmacol; 1988 Mar; 93(3):618-26. PubMed ID: 2836012
[TBL] [Abstract][Full Text] [Related]
8. Peptide models of dynorphin A(1-17) incorporating minimally homologous substitutes for the potential amphiphilic beta strand in residues 7-15.
Taylor JW
Biochemistry; 1990 Jun; 29(22):5364-73. PubMed ID: 1974458
[TBL] [Abstract][Full Text] [Related]
9. Regulatory role of enteric mu and kappa opioid receptors in the release of acetylcholine and norepinephrine from guinea pig ileum.
Nakayama S; Taniyama K; Matsuyama S; Ohgushi N; Tsunekawa K; Tanaka C
J Pharmacol Exp Ther; 1990 Sep; 254(3):792-8. PubMed ID: 1975621
[TBL] [Abstract][Full Text] [Related]
10. Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide.
Martinka GP; Jhamandas K; Sabourin L; Lapierre C; Lemaire S
Eur J Pharmacol; 1991 Apr; 196(2):161-7. PubMed ID: 1678718
[TBL] [Abstract][Full Text] [Related]
11. Interaction of newly synthesized N-cyclopropylmethyl derivatives of (-)-6 beta-acetylthionormorphine with opioid receptors.
Takayanagi I; Goromaru N; Koike K; Konno F; Mori T; Yoshida M; Kanematsu K
Gen Pharmacol; 1990; 21(4):541-6. PubMed ID: 2165960
[TBL] [Abstract][Full Text] [Related]
12. Analgesic, receptor binding, and peripheral opioid activities of synthetic dermorphin-dynorphin hybrid peptides.
Ho CL; Ko JL; Hwang LL; Wang KT
Int J Pept Protein Res; 1990 Feb; 35(2):99-104. PubMed ID: 1969854
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic activity and effects of guanyl-5'-yl imidodiphosphate, Gpp(NH)p and sodium ion on the affinity of dynorphin 1-13, nalorphine and nalorphine-7,8-oxide to kappa-opioid receptor.
Takayanagi I; Okumura K; Konno F; Koike K; Cho N; Hirobe M
Gen Pharmacol; 1985; 16(6):617-9. PubMed ID: 2867951
[TBL] [Abstract][Full Text] [Related]
14. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
Yoshimura K; Huidobro-Toro JP; Lee NM; Löh HH; Way EL
J Pharmacol Exp Ther; 1982 Jul; 222(1):71-9. PubMed ID: 6123594
[No Abstract] [Full Text] [Related]
15. 14-beta-Methyl-8-oxacyclorphan (BC-3016), a morphinan derivative with high affinity for kappa opioid receptor: comparison with dynorphin-A(1-13).
Lemaire S; Dumont M; Jolicoeur F; Belleau B
Can J Physiol Pharmacol; 1986 Jun; 64(6):707-11. PubMed ID: 2875779
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of dynorphin A(1-9) pyrrolidine analogs on isolated tissues.
Rezvani A; Kadambi SR; Rhoads DL; Chang JK; Way EL
NIDA Res Monogr; 1986; 75():228-31. PubMed ID: 2893265
[TBL] [Abstract][Full Text] [Related]
17. Beta-endorphin. Biological activity of analogs containing dermorphin and dynorphin sequences: ileum and vas deferens assays.
Ho CL; Li CH
Int J Pept Protein Res; 1987 Jan; 29(1):134-9. PubMed ID: 2883148
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the action of putative endogenous kappa-agonists, leumorphin and rimorphin in vitro.
Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara C; Yanaihara N; Numa S; Imura H
Life Sci; 1983; 33 Suppl 1():275-8. PubMed ID: 6319876
[TBL] [Abstract][Full Text] [Related]
19. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.
James MK; Feldman PL; Schuster SV; Bilotta JM; Brackeen MF; Leighton HJ
J Pharmacol Exp Ther; 1991 Nov; 259(2):712-8. PubMed ID: 1658308
[TBL] [Abstract][Full Text] [Related]
20. Photoaffinity labeling of opioid receptor with morphine-7,8-oxide (morphine epoxide).
Takayanagi I; Shibata R; Miyata N; Hirobe M
J Pharmacol Methods; 1982 May; 7(3):185-92. PubMed ID: 6287114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
